标题
Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets
作者
关键词
-
出版物
PPAR Research
Volume 2017, Issue -, Pages 1-13
出版商
Hindawi Limited
发表日期
2017-06-05
DOI
10.1155/2017/8360919
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis
- (2017) Hariom Yadav et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast growth factor 21 and its novel association with oxidative stress
- (2017) Miguel Ángel Gómez-Sámano et al. Redox Biology
- Metrnl: a secreted protein with new emerging functions
- (2016) Si-li Zheng et al. ACTA PHARMACOLOGICA SINICA
- His-87 ligand in mitoNEET is crucial for the transfer of iron sulfur clusters from mitochondria to cytosolic aconitase
- (2016) Guoqiang Tan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling
- (2016) Islam Osman et al. BIOCHEMICAL PHARMACOLOGY
- Metformin Activates AMPK through the Lysosomal Pathway
- (2016) Chen-Song Zhang et al. Cell Metabolism
- AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity
- (2016) Ting Luo et al. DIABETES
- Unraveling the actions of AMP-activated protein kinase in metabolic diseases: Systemic to molecular insights
- (2016) Karen A. Weikel et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adiponectin signaling and function in insulin target tissues
- (2016) Hong Ruan et al. Journal of Molecular Cell Biology
- Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones
- (2016) D. Alemán-González-Duhart et al. PPAR Research
- AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings
- (2015) Yanqing Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Mitochondrial pyruvate transport: a historical perspective and future research directions
- (2015) Kyle S. McCommis et al. BIOCHEMICAL JOURNAL
- L312, a novel PPARγ ligand with potent anti-diabetic activity by selective regulation
- (2015) Xinni Xie et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling
- (2015) Kyle S. McCommis et al. Cell Metabolism
- Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue
- (2015) Murielle M. Véniant et al. Cell Metabolism
- Metformin Action: Concentrations Matter
- (2015) Ling He et al. Cell Metabolism
- Adipocyte Metrnl Antagonizes Insulin Resistance Through PPARγ Signaling
- (2015) Zhi-Yong Li et al. DIABETES
- miR-577 inhibits pancreatic β-cell function and survival by targeting fibroblast growth factor 21 (FGF-21) in pediatric diabetes
- (2015) X.Y. Chen et al. GENETICS AND MOLECULAR RESEARCH
- Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice
- (2015) Leping Zhao et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499
- (2015) Soo Young Byun et al. LIFE SCIENCES
- The Role of Vaspin in the Development of Metabolic and Glucose Tolerance Disorders and Atherosclerosis
- (2015) Rumyana Dimova et al. Biomed Research International
- Adipokines as Drug Targets in Diabetes and Underlying Disturbances
- (2015) Vinícius Andrade-Oliveira et al. Journal of Diabetes Research
- Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity
- (2015) Miki Okada-Iwabu et al. Diabetes & Metabolism Journal
- Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy
- (2014) Alba Luengo et al. BMC BIOLOGY
- An Evaluation of MSDC-0160, A Prototype mTOT Modulating Insulin Sensitizer, in Patients with Mild Alzheimer’s Disease
- (2014) Raj Shah et al. Current Alzheimer Research
- Activating HSP72 in Rodent Skeletal Muscle Increases Mitochondrial Number and Oxidative Capacity and Decreases Insulin Resistance
- (2014) Darren C. Henstridge et al. DIABETES
- A Novel Non-agonist Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand UHC1 Blocks PPARγ Phosphorylation by Cyclin-dependent Kinase 5 (CDK5) and Improves Insulin Sensitivity
- (2014) Sun-Sil Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Review on Thiazolidinediones and Bladder Cancer in Human Studies
- (2014) Chin-Hsiao Tseng JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS
- AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease
- (2014) D. Grahame Hardie JOURNAL OF INTERNAL MEDICINE
- Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies
- (2014) Botond Literáti-Nagy et al. Metabolic Syndrome and Related Disorders
- Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer
- (2014) Jae Myoung Suh et al. NATURE
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
- (2014) Bogna Grygiel-Górniak Nutrition Journal
- 11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome
- (2014) Amit Joharapurkar et al. Pharmacological Reports
- Novel PPAR Pan Agonist, ZBH Ameliorates Hyperlipidemia and Insulin Resistance in High Fat Diet Induced Hyperlipidemic Hamster
- (2014) Wei Chen et al. PLoS One
- CMHX008, a Novel Peroxisome Proliferator-Activated Receptor γ Partial Agonist, Enhances Insulin Sensitivity In Vitro and In Vivo
- (2014) Yue Ming et al. PLoS One
- Insulin Receptor Signaling in Normal and Insulin-Resistant States
- (2014) J. Boucher et al. Cold Spring Harbor Perspectives in Biology
- Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone
- (2014) Xianchao Cheng et al. Drug Design Development and Therapy
- A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role
- (2014) Mirella P. Hage et al. Therapeutic Advances in Endocrinology and Metabolism
- AMPK activation: a therapeutic target for type 2 diabetes?
- (2014) Asish Saha et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids
- (2013) Hongliang Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- C333H Ameliorated Insulin Resistance through Selectively Modulating Peroxisome Proliferator-Activated Receptor γ in Brown Adipose Tissue of db/db Mice
- (2013) Ning Zhang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
- (2013) Zhuofeng Lin et al. Cell Metabolism
- Clinical Proof-of-Concept Study With MSDC-0160, a Prototype mTOT-Modulating Insulin Sensitizer
- (2013) J R Colca et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases
- (2013) Jerry R Colca et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- AMPK, insulin resistance, and the metabolic syndrome
- (2013) Neil B. Ruderman et al. JOURNAL OF CLINICAL INVESTIGATION
- A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
- (2013) Miki Okada-Iwabu et al. NATURE
- Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
- (2013) Alexei Kharitonenkov et al. PLoS One
- LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
- (2013) Andrew C. Adams et al. PLoS One
- Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT)—Relationship to Newly Identified Mitochondrial Pyruvate Carrier Proteins
- (2013) Jerry R. Colca et al. PLoS One
- Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
- (2013) A. S. Divakaruni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective PPARγ modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice
- (2012) Dae Ho Lee et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
- (2012) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones
- (2012) Paul A. Dutchak et al. CELL
- Metformin: The hidden chronicles of a magic drug
- (2012) Khalid Mahmood et al. European Journal of Internal Medicine
- Metformin Regulates Glucose Transporter 4 (GLUT4) Translocation through AMP-activated Protein Kinase (AMPK)-mediated Cbl/CAP Signaling in 3T3-L1 Preadipocyte Cells
- (2012) Jung Ok Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
- (2012) Panagiotis Anagnostis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist
- (2012) R. Agrawal et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis
- (2012) Johan W. Jonker et al. NATURE
- Fgf signaling in adipocytes as a target for metabolic diseases
- (2012) Hiroya Ohta et al. Molecular Metabolism
- Fibroblast Growth Factor 21: A Novel Metabolic Regulator
- (2012) Ji A Seo et al. Diabetes & Metabolism Journal
- Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus
- (2011) Adrian V. Hernandez et al. American Journal of Cardiovascular Drugs
- Acute Mitochondrial Actions of Glitazones on the Liver: a Crucial Parameter for their Antidiabetic Properties
- (2011) María-Nieves Sanz et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Novel ligands that target the mitochondrial membrane protein mitoNEET
- (2011) Robert M. Bieganski et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
- (2011) Jang Hyun Choi et al. NATURE
- Membrane-Lipid Therapy in Operation: The HSP Co-Inducer BGP-15 Activates Stress Signal Transduction Pathways by Remodeling Plasma Membrane Rafts
- (2011) Imre Gombos et al. PLoS One
- 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development
- (2010) R. Ge et al. CURRENT MEDICINAL CHEMISTRY
- The 11- -Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
- (2010) J. Rosenstock et al. DIABETES CARE
- Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells
- (2010) Soo Kyung Lee et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Selective peroxisome proliferator-activated receptor γ (PPARγ) modulation as a strategy for safer therapeutic PPARγ activation
- (2009) Linda Slanec Higgins et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
- (2009) S. Fogarty et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Systemic Fate of the Adipocyte-Derived Factor Adiponectin
- (2009) N. Halberg et al. DIABETES
- Review article: Thiazolidinediones and heart failure
- (2009) Parminder S. Chaggar et al. Diabetes & Vascular Disease Research
- Improvement of Insulin Sensitivity by a Novel Drug, BGP-15, in Insulin-resistant Patients: A Proof of Concept Randomized Double-blind Clinical Trial
- (2009) B. Literáti-Nagy et al. HORMONE AND METABOLIC RESEARCH
- Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization
- (2009) D. D. Sears et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peroxisome Proliferator-Activated Receptor δ-Agonist, GW501516, Ameliorates Insulin Resistance, Improves Dyslipidaemia in Monosodium l-Glutamate Metabolic Syndrome Mice
- (2008) Wei Chen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- HSP72 protects against obesity-induced insulin resistance
- (2008) J. Chung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now